PS
GSK icon

Principal Securities’s GSK GSK Stock Holding History

Principal Securities’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.21M Buy
61,149
+5,575
+10% +$295K 0.04% 386
2026
Q1 		$3.07M Buy
55,574
+11,284
+25% +$611K 0.05% 360
2025
Q4 		$2.17M Buy
44,290
+2,717
+7% +$127K 0.03% 449
2025
Q3 		$1.79M Sell
41,573
-23,656
-36% -$924K 0.03% 488
2025
Q2 		$2.5M Buy
65,229
+18,074
+38% +$691K 0.05% 343
2025
Q1 		$1.59M Buy
47,155
+4
+0% +$146 0.04% 424
2024
Q4 		$1.59M Sell
47,151
-5,374
-10% -$193K 0.04% 422
2024
Q3 		$2.15M Sell
52,525
-3,396
-6% -$139K 0.05% 320
2024
Q2 		$2.15M Buy
55,921
+5,252
+10% +$221K 0.06% 287
2024
Q1 		$2.17M Buy
50,669
+303
+0.6% +$12.5K 0.07% 262
2023
Q4 		$1.87M Buy
+50,366
New +$1.81M 0.07% 269

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Principal Securities's GSK Position: Q2 2026 in Review

Principal Securities increased its GSK (GSK) stake by 10% in Q2 2026, buying an estimated $295K and bringing the position to 61,149 shares worth $3.21M. The position accounts for 0.04% of the portfolio, ranked #386.

Principal Securities first reported a position in GSK in Q4 2023 and has held it in 11 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Principal Securities held 61,149 shares of GSK worth $3.21M as of Q2 2026.
  • Principal Securities bought 5,575 GSK shares in Q2 2026, an estimated $295K.
  • GSK made up 0.04% of Principal Securities's portfolio in Q2 2026, its #386 holding.
  • Principal Securities first reported a position in GSK in Q4 2023 and has held it in 11 quarters since.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.